Immunological aspects of age-related diseases

The proportion of elderly people rises in the developed countries. The increased susceptibility of the elderly to infectious diseases is caused by immune dysfunction, especially T cell functional decline. Age-related hematopoietic stem cells deviate from lymphoid lineage to myeloid lineage. Thymus s...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of biological chemistry Vol. 8; no. 2; pp. 129 - 137
Main Authors Isobe, Ken-Ichi, Nishio, Naomi, Hasegawa, Tadao
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 26.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The proportion of elderly people rises in the developed countries. The increased susceptibility of the elderly to infectious diseases is caused by immune dysfunction, especially T cell functional decline. Age-related hematopoietic stem cells deviate from lymphoid lineage to myeloid lineage. Thymus shrinks early in life, which is followed by the decline of na?ve T cells. T-cell receptor repertoire diversity declines by aging, which is caused by cytomegalovirus-driven T cell clonal expansion. Functional decline of B cell induces antibody affinity declines by aging. Many effector functions including phagocytosis of myeloid cells are down regulated by aging. The studies of aging of myeloid cells have some controversial results. Although M1 macrophages have been shown to be replaced by antiinflammatory(M2) macrophages by advanced age, many human studies showed that pro-inflammatory cytokines are elevated in older human. To solve this discrepancy here we divide age-related pathological changes into two categories. One is an aging of immune cell itself. Second is involvement of immune cells to age-related pathological changes. Cellular senescence and damaged cells in aged tissue recruit pro-inflammatory M1 macrophages, which produce pro-inflammatory cytokines and proceed to agerelated diseases. Underlying biochemical and metabolic studies will open nutritional treatment.
Bibliography:Ken-ichi Isobe;Naomi Nishio;Tadao Hasegawa;Department of Food Science and Nutrition, Nagoya Woman’s University;Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Author contributions: All the authors contributed to this manuscript.
Correspondence to: Ken-ichi Isobe, MD, PhD, Professor, Department of Food Science and Nutrition, Nagoya Woman’s University, 3-40 Shioji-cho, Mizuho-ku, Nagoya 467-8610, Japan. isobe@nagoya-wu.ac.jp
Telephone: +81-52-8529425 Fax: +81-52-8527470
ISSN:1949-8454
1949-8454
DOI:10.4331/wjbc.v8.i2.129